Popular on TelAve
- FirstFruits Farms and Opal Partner with the Junior Basketball League to Empower Youth Through Nutrition and Sport
- Peachtree Immediate Care Opens Two New Locations in December
- Webinar Announcement: Navigating the New Investment Adviser AML Mandate: What Steps Should Investment Advisers Be Taking Now?
- Industry-Changing Multi-Benefit Service Platform for Technology Systems & AI Smart Devices Drives; 218% Revenue Growth for Tekumo: Stock Symbol: TKMO
- Somebody's Husband by Robbi Renee Earns Early Acclaim for Its Powerful Exploration of Love, Loss, and Healing
- OmegaBrand Introduces New Thermal Transfer Ribbons for Honeywell PC45t Printers
- Texas Center For Oral Surgery & Dental Implants Launches Redesigned Website to Enhance Patient Experience
- New Age of Law Firm Website Design
- New Drug Application to the FDA for the Treatment of Suicidal Depression that Affects 13+ Million Americans Each Year: NRx Pharma: Stock Symbol:NRXP
- Stan Fitzgerald: A Profile in Resilience and Leadership with VFAF Veterans for America First Organizational Support for a Presidential Pardon
Similar on TelAve
- Dr. Lauren Anderson Led a Successful CE Event: Digital Planning and Execution
- Orcas Island Property Owner Returns Two Prime Waterfront Properties to the Market
- Latest Updates to Pennsylvania Medical Malpractice and Birth Injury Law
- CCHR Cites Newly Released Mind Control Records to Oppose Psychedelics
- Pawganja Token: Redefining Cryptocurrency with Transparency and Philanthropy
- Investor Workshop at Mar-A-Lago, $27 Million for Acquisitions and Drug Treatment of Suicidal Depression: NRx Pharmaceuticals, Inc. (Stock S: NRXP)
- SCOPY.ME - Revolutionizes Business Strategy Development with AI-Powered Platform
- The Dental Specialists in Newton, MA, Introduces Cutting-Edge 3Shape TRIOS 5 Intraoral Scanner
- Agreement for $27 Million in Funding for Expanding Clinic Acquisitions and Operations,: NRx Pharmaceuticals, Inc. Stock Symbol: NRXP)
- Watchdog Reviews Milestones in Exposing Psychiatric Human Rights Abuses in 2024
Actuated Medical President & CEO Appointed as Chair of the Industrial Advisory Board for the Penn State Center for Biodevices
TelAve News/10850556
BELLEFONTE, Pa. - TelAve -- Maureen L. Mulvihill, Ph.D., President & CEO of Actuated Medical, has been named Chair of the Industrial Advisory Board for the Penn State Center for Biodevices. A founding member of the board since its inception in August 2020, Dr. Mulvihill brings a wealth of expertise and a strong commitment to driving innovation in the biomedical field. She will lead the board in this pivotal role during a two-year term, guiding strategic initiatives and strengthening collaboration between academia and industry.
"Collaborations between academia and the medical device industry are essential for fostering innovation and driving meaningful advancements that benefit faculty, students, and industry leaders alike. I am excited to lead the board over the next two years and am deeply committed to accelerating the center's mission of shaping the future of medical device development."
— Maureen L. Mulvihill, Ph.D., Actuated Medical President & CEO
"We are thrilled to welcome Dr. Mulvihill as the chair of our Industrial Advisory Board. Her exceptional expertise and leadership in the medical device industry, combined with her commitment to fostering innovation, will be invaluable as we continue to bridge the gap between academia and industry. We are confident that her vision and guidance will drive impactful collaborations and further our mission to advance biomedical technologies that improve lives."
More on TelAve News
— Mary Frecker, Ph.D., Director, Penn State Center of Biodevices, Professor of Mechanical Engineering and Biomedical Engineering, Riess Chair in Engineering
The Penn State Center for Biodevices is a multidisciplinary hub dedicated to advancing innovation and collaboration in the field of biomedical devices. It brings together experts from engineering, medicine, science, and industry to address critical challenges in healthcare through cutting-edge research and development. The center fosters opportunities for faculty, students, and industry partners to collaborate on the creation of novel medical technologies, from early-stage concepts to commercialization. By providing access to state-of-the-art facilities, resources, and a collaborative network, the center aims to drive impactful solutions that improve patient care and healthcare outcomes.
About Actuated Medical, Inc.
Actuated Medical is a medical technology innovator that is pioneering motion-based solutions to address critical, unmet clinical needs in gastroenterology and neurology. With an unwavering focus on innovation, safety, and superior quality, the Actuated team is committed to delivering transformative products that empower healthcare professionals to achieve greater precision, enhance efficiency, and drive better patient outcomes while reducing healthcare costs. The company's technologies are backed by a strategic path to commercialization with multiple exit opportunities, supported by invaluable feedback from industry leaders. Actuated holds 42 issued U.S. and international patents, 8 FDA 510(k) clearances, 5 Investigational Device Exemptions (IDEs), 33 pre-submissions, and has completed or is conducting 8 clinical studies. Honored with two Small Business Administration (SBA) Tibbetts Awards for SBIR commercialization excellence (2014 & 2020), Actuated operates out of a state-of-the-art 20,000 sq. ft. facility in central Pennsylvania, certified with ISO 13485 and as a Woman-Owned Small Business (WOSB), reflecting its steadfast commitment to quality and innovation. actuatedmedical.com
More on TelAve News
About Penn State Center for Biodevices
Established in 2020, the Center for Biodevices aims to bridge foundational science and clinical applications of biodevices, while enabling success of faculty, clinicians, and students across multiple disciplines.
###
For media inquiries, please contact Maureen L. Mulvihill, Ph.D. by phone at 814-355-0003 or email at info@actuatedmedical.com.
Additional information can be found by visiting:
ActuatedMedical.com
GripTract.com
ActuatedNeuroscience.com
TubeClear.com
Mitotyping.com
"Collaborations between academia and the medical device industry are essential for fostering innovation and driving meaningful advancements that benefit faculty, students, and industry leaders alike. I am excited to lead the board over the next two years and am deeply committed to accelerating the center's mission of shaping the future of medical device development."
— Maureen L. Mulvihill, Ph.D., Actuated Medical President & CEO
"We are thrilled to welcome Dr. Mulvihill as the chair of our Industrial Advisory Board. Her exceptional expertise and leadership in the medical device industry, combined with her commitment to fostering innovation, will be invaluable as we continue to bridge the gap between academia and industry. We are confident that her vision and guidance will drive impactful collaborations and further our mission to advance biomedical technologies that improve lives."
More on TelAve News
- Orcas Island Property Owner Returns Two Prime Waterfront Properties to the Market
- Muench Workshops Welcomes New Partners Luke Dray and Sara Linssen, Announces Retirement of Andy Williams
- NuNorm Announces Stop Soldier Suicide as This Year's EQUAL Grant Recipient
- Darrin Jones: The Creative Force Behind the Trends—Raising Questions About Influence in The Weeknd's Music
- Foresight Practitioner Conference 2025 – Dates, Venue, Speakers, And Competition Finalists Announced
— Mary Frecker, Ph.D., Director, Penn State Center of Biodevices, Professor of Mechanical Engineering and Biomedical Engineering, Riess Chair in Engineering
The Penn State Center for Biodevices is a multidisciplinary hub dedicated to advancing innovation and collaboration in the field of biomedical devices. It brings together experts from engineering, medicine, science, and industry to address critical challenges in healthcare through cutting-edge research and development. The center fosters opportunities for faculty, students, and industry partners to collaborate on the creation of novel medical technologies, from early-stage concepts to commercialization. By providing access to state-of-the-art facilities, resources, and a collaborative network, the center aims to drive impactful solutions that improve patient care and healthcare outcomes.
About Actuated Medical, Inc.
Actuated Medical is a medical technology innovator that is pioneering motion-based solutions to address critical, unmet clinical needs in gastroenterology and neurology. With an unwavering focus on innovation, safety, and superior quality, the Actuated team is committed to delivering transformative products that empower healthcare professionals to achieve greater precision, enhance efficiency, and drive better patient outcomes while reducing healthcare costs. The company's technologies are backed by a strategic path to commercialization with multiple exit opportunities, supported by invaluable feedback from industry leaders. Actuated holds 42 issued U.S. and international patents, 8 FDA 510(k) clearances, 5 Investigational Device Exemptions (IDEs), 33 pre-submissions, and has completed or is conducting 8 clinical studies. Honored with two Small Business Administration (SBA) Tibbetts Awards for SBIR commercialization excellence (2014 & 2020), Actuated operates out of a state-of-the-art 20,000 sq. ft. facility in central Pennsylvania, certified with ISO 13485 and as a Woman-Owned Small Business (WOSB), reflecting its steadfast commitment to quality and innovation. actuatedmedical.com
More on TelAve News
- Latest Updates to Pennsylvania Medical Malpractice and Birth Injury Law
- Best Plant Varieties for Windbreaks and Shelterbelts
- Genuine Hospitality, LLC Expands Leadership Team with Key Appointments
- New-and-Improved Caribbean-Food Website Dishes Out Free Ground-Shipping Offer; Affiliate Program Garnished with Generous Commission
- 50th Mount Dora Arts Festival set for Feb 1 and 2, 2024
About Penn State Center for Biodevices
Established in 2020, the Center for Biodevices aims to bridge foundational science and clinical applications of biodevices, while enabling success of faculty, clinicians, and students across multiple disciplines.
###
For media inquiries, please contact Maureen L. Mulvihill, Ph.D. by phone at 814-355-0003 or email at info@actuatedmedical.com.
Additional information can be found by visiting:
ActuatedMedical.com
GripTract.com
ActuatedNeuroscience.com
TubeClear.com
Mitotyping.com
Source: Actuated Medical, Inc.
Filed Under: Technology
0 Comments
Latest on TelAve News
- Transform Warehouse Operations: Redefining Logistics with Customized Solutions
- NaturismRE Introduces Global Accreditation Standards to Redefine Nudist and Naturist Venues
- Enhancing Campus Safety for Women: The Blue Luna's New Initiative
- More high-priority SIGINT solutions were announced for Krypto1000 SIGINT software
- SCOPY.ME - Revolutionizes Business Strategy Development with AI-Powered Platform
- TimelyBill to Showcase Innovation at ITEXPO
- Moonshot Announces 6th Annual 2025 Rural Arizona Pitch Competition Tour with Bilingual Resources and Mentors
- The Dental Specialists in Newton, MA, Introduces Cutting-Edge 3Shape TRIOS 5 Intraoral Scanner
- Pikmykid Acquires Visitu to Enhance School Visitor Management Solutions
- Project EverGreen's SnowCare for Troops Program Helps Military Families Weather the Winter During Awareness Month in January
- Celebrate Love in Style: Introducing the Signature Summer Bundle for 2025 Weddings
- MileMark Explains Latest ABA Rules On Attorney Advertising
- The Annual Kingdom Day Parade Celebrates 40th Anniversary With Its " 40th Annual Kingdom Day Parade"
- Morningscore Secures $700k in Funding to Build the Next Generation of AI SEO and Expand Globally
- Certified Nutraceuticals Partners with Colorado Researchers for Groundbreaking Study on KollaJell™ and Brain Health
- GD Nationwide: 2024 Recap and 2025 Preview
- Preserving Mikaben's Legacy: A Plea For Unity And Respect
- Globally-renowned scholar Dalia Mogahed Joins Origins Consulting Group as Senior Adviser on Islamophobia
- Agreement for $27 Million in Funding for Expanding Clinic Acquisitions and Operations,: NRx Pharmaceuticals, Inc. Stock Symbol: NRXP)
- Author and Speaker El-Hajj Maurice Crawford Shabazz Releases New Book